Cargando…
Predictors of residual pulmonary vascular obstruction after anticoagulation monotherapy in patients with intermediate-risk pulmonary embolism
BACKGROUND: Patients with intermediate-risk pulmonary embolism (PE) can be treated with anticoagulation monotherapy. However, clinicians are concerned as to whether anticoagulation monotherapy is sufficient to reduce mortality in patients with a large embolic burden, and to resolve vascular obstruct...
Autores principales: | Chang, Youjin, Moon, Jae Young, Park, Jae-Hyeong, Choi, Sangbong, Lee, Hyuk Pyo, Sim, Jae Kyeom, Lee, Young Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339779/ https://www.ncbi.nlm.nih.gov/pubmed/34422350 http://dx.doi.org/10.21037/jtd-21-403 |
Ejemplares similares
-
Role of echocardiography in acute pulmonary embolism
por: Oh, Jin Kyung, et al.
Publicado: (2023) -
Safety of early orthopedic surgery in patients with intermediate/low- or low-risk pulmonary embolism
por: Kim, Ho Cheol, et al.
Publicado: (2020) -
Pulmonary Sarcoidosis Induced by Adalimumab: A Case Report and Literature Review
por: Sim, Jae Kyeom, et al.
Publicado: (2016) -
Prognostic marker for severe acute exacerbation of chronic obstructive pulmonary disease: analysis of diffusing capacity of the lung for carbon monoxide (D(LCO)) and forced expiratory volume in one second (FEV(1))
por: Choi, Juwhan, et al.
Publicado: (2021) -
Intermediate-High Risk Pulmonary Embolism
por: Mirambeaux, Rosa, et al.
Publicado: (2019)